u-blox (UBXN) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
23 Nov, 2025Board's rationale and valuation process
Share price was negotiated using both internal and independent external sources, including a fairness opinion from IFBC, which aligned with the offer price.
The Board concluded the offer represents a fair value based on all available input and long-term business plans.
Board of Directors unanimously recommends shareholders accept the offer, supported by an independent fairness opinion.
Both management and board believe the deal benefits shareholders, customers, and employees.
No formal sales process was run; discussions were bilateral with Advent, though regular contact with industry peers was maintained.
Offer details and financial terms
Public tender offer at CHF 135.00 per share in cash, representing a 53% premium to the 6-month average and 32% to the 60-day average share price until August 14, 2025.
The offer values the target's equity at approximately CHF 1,050 million on a fully diluted basis.
Acceptance threshold for the offer is set at two-thirds of shares, with the offer expected to close around August 27.
Largest individual shareholder, holding about 9%, has committed to tender all shares.
Management and board have committed to tender all their shares.
Regulatory process and requirements
All appropriate regulatory processes will be followed, with no major risks anticipated.
Offer is subject to customary terms, conditions, and regulatory approvals for this type of transaction.
The offer will comply with Swiss law and certain U.S. securities law exemptions, with differences in procedures for U.S. holders.
Completion of the transaction is subject to regulatory approvals and other customary conditions.
Forward-looking statements are subject to risks and uncertainties; no assurance of deal completion.
Latest events from u-blox
- Revenue dropped sharply, but cost savings and new wins support a gradual recovery.UBXN
H1 20242 Feb 2026 - Q3 revenue up sequentially, Q4 slows on auto weakness; cost savings and 2025 growth expected.UBXN
Q3 2024 TU19 Jan 2026 - Phasing out cellular will cut CHF 30m in losses and sharpen focus on GNSS and short-range growth.UBXN
Investor Update10 Jan 2026 - Q1 2025 revenue up 26% year-over-year, with Locate and Short-range surging and profitability improving.UBXN
Q1 2025 TU27 Dec 2025 - Trasna acquires cellular business, enabling core focus and growth in Locate and Short Range.UBXN
Investor Update24 Dec 2025 - Strategic shift to Locate, cost cuts, and improved margins set up for 2025 recovery.UBXN
H2 202416 Dec 2025 - Revenue up 19% year-over-year; Q4 guidance: CHF 60–70 million, EBIT margin 0–10%.UBXN
Q3 2025 TU22 Oct 2025 - 32% revenue growth, margin improvement, and divestment mark a pivotal financial turnaround.UBXN
H1 202512 Aug 2025